Philips has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its next-generation reusable SpO₂ clip sensor.
The product is designed to provide consistent oxygen saturation measurements for a variety of patient groups and clinical conditions.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The sensor features internal optical enhancements intended to improve signal quality and measurement accuracy.
In performance tests cited by the company, the SpO₂ clip sensor attained an Accuracy Root Mean Square (ARMS) value of 1.6%.
Philips stated that the device maintained consistent performance across a wide range of skin tones. Specifically, the accuracy varied by less than 0.5% between groups with light and dark pigmentation when tested in an SpO₂ range of 85%-100%.
Philips clinical measurements and specialty monitoring category leader Sachin Chaudhari said: “Providing clinicians with reliable data to deliver better care to more people is at the heart of everything we do.
“This FDA clearance reflects our ongoing investment in advancing sensor technology and rigorous validation practices, and we’ll continue applying these innovations across our pulse oximetry portfolio so clinicians can make care decisions with even greater confidence.”
Philips’ new sensor has been evaluated under a programme that assesses performance across different populations, including diverse skin tones and various physiological and clinical scenarios.
The company described its validation approach as aligning with evolving FDA guidance and international standards set by ISO and the International Electrotechnical Commission (IEC).
The Philips SpO₂ clip sensor is expected to be available in selected global markets later in the year.
Philips indicated continued collaboration with clinicians, researchers, regulators, and standards organisations to further develop pulse oximetry evaluation and validation practices.
Last month, the company received 510(k) clearance for Elevate Plus, an upgrade that adds new imaging and AI capabilities to its EPIQ Elite and Affiniti ultrasound systems.
